DeForge v. GlaxoSmithKline, LLC et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
Florida Southern District Court | |
Judge: | Robin L Rosenberg |
Referred: | Bruce E Reinhart |
Case #: | 9:24-cv-80468 |
Nature of Suit | 365 Torts - Personal Injury - Product Liability |
Cause | 28:1332 Diversity-Petition for Removal |
Case Filed: | Apr 15, 2024 |
Terminated: | Apr 15, 2024 |
Case in other court: | California Northern, 3:24-cv-01903 |
Last checked: Saturday Oct 12, 2024 6:36 AM EDT |
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Represented By
|
Defendant
Boehringer Ingelheim U.S.A. Corporation
|
Represented By
|
Defendant
GlaxoSmithKline LLC
|
Represented By
|
Defendant
Patheon
|
|
Defendant
Pfizer Inc
|
Represented By
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
Plaintiff
Christopher DeForge
|
Represented By
|
Docket last updated: 11 hours ago |
Wednesday, June 05, 2024 | ||
27 | 27
notice
Notice of Voluntary Dismissal - aty
Wed 06/05 6:23 PM
NOTICE of Voluntary Dismissal without prejudice by Christopher DeForge. Attorney Behram V. Parekh added to party Christopher DeForge(pty:pla). (Parekh, Behram) |
|
Monday, April 15, 2024 | ||
26 | 26
4
pgs
order
Order Staying Case
Mon 04/15 5:16 PM
PRETRIAL ORDER # 80 Procedures for the Filing of All Future Claims in this MDL. Case is Administratively Closed and Stayed. Signed by Judge Robin L. Rosenberg on 4/15/2024. See attached document for full details. (jas) |
|
25 | 25
order
Clerk's Notice of Judge Assignment and Optional Consent
Mon 04/15 5:14 PM
Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg and Magistrate Judge Bruce E. Reinhart. (jas) |
|
24 | 24
transfer
MDL Tag-Along/Transfer In Case Receipt
Mon 04/15 5:12 PM
MDL Transfer In Case Receipt from the Northern District of California. Case Number 24-cv-01903-TLT with documents 1-22. Assigned FLSD Case Number 24-cv-80468-RLR. Re: FLSD MDL Case Number 20-md-2924-RLR (jas) |
|
23 | 23
transfer
Case Transferred In - District Transfer - CV - NO FEE
Mon 04/15 4:48 PM
Case transferred in from California Northern; Case Number 3:24-cv-01903. Electronic file including transfer order and docket sheet received. .(jas) |
|
Friday, April 12, 2024 | ||
22 | 22 CONDITIONAL TRANSFER ORDER (CTO-125) from the Judicial Panel on Multidistrict Litigation, pursuant to 28 USC 1407, transferring case "DeForge v. GlaxoSmithKline, LLC et al", 3:24-cv-01903-TLT to the Southern District of Florida to become part of MDL 2924.(dhm, COURT STAFF) | |
Att: 1 MDL Transmittal Letter | ||
Wednesday, April 10, 2024 | ||
21 | 21 ORDER GRANTING 9 MOTION TO STAY ALL PROCEEDINGS PENDING TRANSFER TO MULTIDISTRICT LITIGATION. Signed by Judge Trina L Thompson on 4/9/2024. (rfm, COURT USER) | |
Monday, April 08, 2024 | ||
20 | 20 Renotice motion hearing re9 MOTION to Stay All Proceedings Pending Transfer to Multidistrict Litigation filed byGlaxoSmithKline, LLC. (Bhimani, Jay) | |
Friday, April 05, 2024 | ||
19 | 19 Certificate of Interested Entities by Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation identifying Corporate Parent Boehringer Ingelheim International GMBH for Boehringer Ingelheim USA Corporation; Corporate Parent Boehringer Ingelheim Corporation, Corporate Parent Boehringer Ingelheim USA Corporation for Boehringer Ingelheim Pharmaceuticals, Inc.. DEFENDANT BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. AND BOEHRINGER INGELHEIM USA CORPORATION, INC.S RULE 7.1 DISCLOSURE STATEMENT AND CIVIL LOCAL RULE 3-15 CERTIFICATION OF INTERESTED ENTITIES OR PERSONS (Blaschke, Matthew) | |
18 | 18 NOTICE of Appearance by Matthew J. Blaschke FOR DEFENDANT BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. AND BOEHRINGER INGELHEIM USA CORPORATION, INC. (Blaschke, Matthew) | |
17 | 17 ORDER REASSIGNING CASE. Case reassigned to Judge Trina L Thompson for all further proceedings. Magistrate Judge Kandis A. Westmore no longer assigned to case,. Signed by Clerk on 4/5/2024. (ark, COURT STAFF) | |
Thursday, April 04, 2024 | ||
16 | 16 ORDER GRANTING ADMINISTRATIVE MOTIONS TO CONSIDER WHETHER CASE SHOULD BE RELATED. Related Cases: 3:20-cv-03913, 3:24-cv-01880. Signed by Judge Trina L. Thompson on 4/4/2024. (rfm, COURT USER) | |
Tuesday, April 02, 2024 | ||
15 | 15 CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re12 Stipulation,11 Notice (Other) (Bhimani, Jay) | |
Monday, April 01, 2024 | ||
14 | 14 CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re9 MOTION to Stay All Proceedings Pending Transfer to Multidistrict Litigation (Bhimani, Jay) | |
13 | 13 Rule 7.1 Disclosures by Sanofi-Aventis U.S., LLC identifying Corporate Parent Sanofi for Sanofi-Aventis U.S., LLC. (Huynh, Tommy) | |
12 | 12 STIPULATION to Extend Time to Answer or Otherwise Respond to Complaint filed by GlaxoSmithKline, LLC. (Bhimani, Jay) | |
11 | 11 NOTICE by GlaxoSmithKline, LLC of Defendants' Notice of Related Case(Bhimani, Jay) | |
Att: 1 Exhibit A | ||
Friday, March 29, 2024 | ||
10 | 10 CERTIFICATE OF SERVICE by GlaxoSmithKline, LLC re5 Notice of Appearance,3 Initial Case Management Scheduling Order with ADR Deadlines,6 Notice of Appearance,1 Notice of Removal,4 Administrative Motion to Consider Whether Another Party's Material Should Be Sealed ,7 Certificate of Interested Entities (Bhimani, Jay) | |
9 | 9 MOTION to Stay All Proceedings Pending Transfer to Multidistrict Litigation filed by GlaxoSmithKline, LLC. Motion Hearing set for 5/16/2024 01:30 PM in Oakland, - Videoconference Only before Magistrate Judge Kandis A. Westmore. Responses due by 4/12/2024. Replies due by 4/19/2024.(Bhimani, Jay) | |
Att: 1 Proposed Order, | ||
Att: 2 Exhibit A, | ||
Att: 3 Exhibit B | ||
Thursday, March 28, 2024 | ||
8 | 8 Rule 7.1 Disclosures by Pfizer Inc. (Campagne, Ingrid) | |
7 | 7 Corporate Disclosure Statement by GlaxoSmithKline, LLC identifying Corporate Parent GlaxoSmithKline plc for GlaxoSmithKline, LLC. (Bhimani, Jay) | |
6 | 6 NOTICE of Appearance by Mary H. Kim (Kim, Mary) | |
5 | 5 NOTICE of Appearance by Jay L. Bhimani (Bhimani, Jay) | |
4 | 4 Administrative Motion to Consider Whether Another Party's Material Should Be Sealed filed by GlaxoSmithKline, LLC.(Bhimani, Jay) | |
Att: 1 Proposed Order, | ||
Att: 2 Exhibit 1, | ||
Att: 3 Exhibit 2 | ||
3 | 3 Initial Case Management Scheduling Order with ADR Deadlines: Case Management Statement due by 6/25/2024. Initial Case Management Conference set for 7/2/2024 01:30 PM in Oakland, - To be held by Zoom. (dhm, COURT STAFF) | |
2 | 2 Case assigned to Magistrate Judge Kandis A. Westmore. Counsel for plaintiff or the removing party is responsible for serving the Complaint or Notice of Removal, Summons and the assigned judge's standing orders and all other new case documents upon the opposing parties. For information, visit E-Filing A New Civil Case at http://cand.uscourts.gov/ecf/caseopening. Standing orders can be downloaded from the court's web page at www.cand.uscourts.gov/judges. Upon receipt, the summons will be issued and returned electronically. A scheduling order will be sent by Notice of Electronic Filing (NEF) within two business days. Consent/Declination due by 4/11/2024. (cv, COURT STAFF) | |
1 | 1 NOTICE OF REMOVAL of Action Pursuant to 28 U.S.C. §§ 1332, 1441, and 1446 from Superior Court of Alameda County. Their case number is 23cv058884. (Filing fee $405 receipt number ACANDC-19267679). Filed by GlaxoSmithKline, LLC.(Bhimani, Jay) | |
Att: 1 Exhibit A, | ||
Att: 2 Exhibit B, | ||
Att: 3 Exhibit C, | ||
Att: 4 Exhibit D, | ||
Att: 5 Exhibit E, | ||
Att: 6 Civil Cover Sheet |